THE PPAR- DELTA AGONIST SELADELPAR NORMALIZES PRIMARY BILIARY CHOLANGITIS-LIKE FEATURES IN HUMAN CHOLANGIOCYTES AND REDUCES PATHOLOGICAL IMMUNE ACTIVATION Francisco Caballero-Camino, Irune Lasa,Ainhoa Lapitz, Xia Wu,Pedro Rodrigues, Noelia Pastor-Toyos,Laura Izquierdo-Sanchez,Jiangao Song,Edward Cable,Jeffrey Johnson,Yun-Jung Choi,Charles McWherter,Jesus BanalesHEPATOLOGY(2024)引用 0|浏览3AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要